BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7882279)

  • 1. Multiple genetic lesions in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
    Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage.
    Fracchiolla NS; Pruneri G; Pignataro L; Carboni N; Capaccio P; Boletini A; Buffa R; Neri A
    Cancer; 1997 Mar; 79(6):1114-21. PubMed ID: 9070488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
    Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O
    J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of laryngeal squamous cell carcinoma.
    Nadal A; Cardesa A
    Virchows Arch; 2003 Jan; 442(1):1-7. PubMed ID: 12536308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
    Sakata K
    J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations and amplification of oncogenes in endometrial cancer.
    Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
    Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of cancer-related genes in glass fiber-induced transformed cells.
    Whong WZ; Gao HG; Zhou G; Ong T
    J Toxicol Environ Health A; 1999 Mar; 56(6):397-404. PubMed ID: 10096362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.
    Sakai E; Rikimaru K; Ueda M; Matsumoto Y; Ishii N; Enomoto S; Yamamoto H; Tsuchida N
    Int J Cancer; 1992 Dec; 52(6):867-72. PubMed ID: 1459726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
    Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
    Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
    Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J
    Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Capaccio P; Carboni N; Pagliari AV; Neri A; Ronchett D; Pruner G; Silvotti MG; Pignataro L; Buffa R; Broich G
    Anticancer Res; 1999; 19(2A):1043-51. PubMed ID: 10368653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas.
    Ikeda Y; Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
    Ann Thorac Surg; 1996 Sep; 62(3):835-8. PubMed ID: 8784015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.